PFKFB3 and COVID-19: Metabolic interventions targeting pathways like 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) inhibition may prove particularly valuable for managing COVID-19-associated neutrophilia and its complications [25].